227
Views
8
CrossRef citations to date
0
Altmetric
Original

THE HEMODYNAMIC EFFECTS OF DIASPIRIN CROSS-LINKED HEMOGLOBIN IN DOPAMINE-RESISTANT ENDOTOXIC SHOCK IN SWINE *

, M.D., , M.D., , Ph.D., , , B.S. & , M.D.
Pages 83-98 | Published online: 11 Jul 2009

Figures & data

Figure 1. The hemodynamic effects of endotoxemia in swine with and without dopamine (DA) resuscitation and DCLHb and hetastarch (HETA) salvage. Pigs were administered LPS. Group I pigs received no treatment. In treatment Groups II and III, DA was administered when “sepsis” developed (≥30% decline in MAP). When “dopamine resistance” occurred (20 μg/kg/min failed to restore MAP to baseline), hetastarch (Group II) and DCLHb (Group III) were added. Time 0=pre-LPS infusion. Values are mean±SEM. Only comparisons of CI were significantly different (p≤0.05).

Figure 1. The hemodynamic effects of endotoxemia in swine with and without dopamine (DA) resuscitation and DCLHb and hetastarch (HETA) salvage. Pigs were administered LPS. Group I pigs received no treatment. In treatment Groups II and III, DA was administered when “sepsis” developed (≥30% decline in MAP). When “dopamine resistance” occurred (20 μg/kg/min failed to restore MAP to baseline), hetastarch (Group II) and DCLHb (Group III) were added. Time 0=pre-LPS infusion. Values are mean±SEM. Only comparisons of CI were significantly different (p≤0.05).

Figure 2. The hemodynamic effects of DCLHb vs. hetastarch in DA-resistant shock. “BL” (pre-LPS infusion), “SEP” (“sepsis”) (pre-DA infusion), “DR 0” (“dopamine resistance”) (DR-new time 0). Values are mean±SEM. Only comparisons of HR and MPAP were significantly different (p≤0.05).

Figure 2. The hemodynamic effects of DCLHb vs. hetastarch in DA-resistant shock. “BL” (pre-LPS infusion), “SEP” (“sepsis”) (pre-DA infusion), “DR 0” (“dopamine resistance”) (DR-new time 0). Values are mean±SEM. Only comparisons of HR and MPAP were significantly different (p≤0.05).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.